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Background: Patellofemoral pain syndrome (PFPS) is a frequent cause of anterior knee pain predominantly
affecting young female patients who do not have significant chondral damage. Development of PFPS is probably
multifactorial, involving various knee, hip, and foot kinematic factors. Biomechanical studies have described patellar
maltracking and dynamic valgus (functional malalignment) in patients with patellofemoral pain syndrome. The
literature provides evidence for short-term use of nonsteroidal anti-inflammatory drugs; short-term medially directed
taping; and exercise programs focusing on the lower extremity, hip, and trunk muscles. Evidence supporting the
use of patellar braces is limited because previous studies have been low quality. The aim of this article is to publish
the design of a prospective randomized trial that examines the outcomes of patients with PFPS after treatment with
a new patellar brace (Patella Pro) that applies medially directed force on the patella.
Methods/Design: For this multicenter trial, 156 patients (adolescents and young adults) with PFPS were recruited
from orthopedic practices and orthopedic hospitals and randomly allocated to 3 months of supervised
physiotherapy in combination with the Patella Pro brace or supervised physiotherapy alone. The primary outcome
measures are pain (numerical analog scale); knee function (Kujala score and Knee Injury and Osteoarthritis Outcome
Score); and self-reported perception of recovery at baseline, 6 weeks, 3 months, and 1 year.
Discussion: Only limited evidence for the use of a patellar brace for the treatment of PFPS exists in the literature.
Disputable evidence for the use of orthoses for PFPS patients has been presented in one meta-analysis, in which
only one of three studies found the effect of a medially directed patellar brace to be significant. Because of these
low-quality studies, the authors concluded that this evidence should be regarded as limited, and we feel there is a
need for further well-designed studies to evaluate the effect of patellar bracing on PFPS-related pain. The Patella
Pro study is a prospective randomized trial in which supervised physiotherapy in combination with a patellar brace
is compared with supervised physiotherapy alone. This trial started in April 2012 and finished in October 2013.
Trial registration: DRKS-ID:DRKS00003291, January 3rd, 2012
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The incidence of anterior knee pain is high. Callaghan and
Selfe conducted a literature search of English-language
publications dated from January 2000 to December 2005
that showed the incidence of patellofemoral pain syn-
drome (PFPS) to be between 3% and 40% [1]. The authors
found that evidence for the incidence of PFPS was taken
almost entirely from source data in sports medicine or
military settings [1]. Women are affected more than twice
as often as men [2-4].
Patellofemoral pain syndrome (PFPS) is a common
cause of anterior knee pain and mainly affects young
women who do not have significant pathological changes
in articular cartilage [3-9]. Therefore, PFPS is mainly a
diagnosis of exclusion and, as such, demands careful
clinical examination [5], which can detect such charac-
teristics of PFPS as patellar maltracking [10].
A classic PFPS symptom is anterior knee pain that is
provoked by prolonged sitting with bent knees, stair climb-
ing, and sports activities [5-8]. Other associated manifesta-
tions include crepitus and functional deficit [5-8]. PFPS
symptoms cause many athletes to limit their sports activ-
ities [2], and some authors have stated that PFPS can con-
tribute to long-term patellofemoral osteoarthritis [11,12].
The role of patellar maltracking in the emergence of
PFPS has long been a controversial issue. Recent studies,
however, show that maltracking of the patella probably
plays a key role [13-15]. There is evidence in the literature
that the cause of patellar maltracking and subsequent im-
balance of the vastus medialis and lateralis in some pa-
tients with PFPS may not be structural in nature; rather,
dynamic or functional malalignment may underlie PFPS
in these patients [6,7]. Functional or dynamic valgus may
influence patellar tracking and lead to lateralization of the
patella [14]. Recent research has shown that functional
malalignment does not originate in the knee joint but re-
sults from internal rotation of the femur due to weakness
of hip external rotators and abductors (gluteus medius
and minimus) [16-19]. Further muscular imbalances in-
volving the quadriceps and hamstrings can be found in
these patients [20-22].
Muscular dysfunction probably plays a key role in the
pathogenesis of PFPS; therefore, physiotherapy is the most
frequently studied form of treatment [23,24], and there is
strong evidence for the role of exercise in the treatment of
PFPS in the literature. In a recent meta-analysis of 10 pro-
spective randomized studies [23], each showed a positive
effect of exercise on pain reduction. Positive results have
been attributed to active stretching exercises, squats, cycle
ergometry, isometric quadriceps exercises, active leg
raises, leg press, and ascending and descending climbing
exercises. Four of the exercise programs also included
exercises to strengthen the hip abductors. In one study,
exercises to stabilize the trunk, including the rectusabdominis, were analyzed. The most frequent duration of
the exercise programs was 6 weeks, and exercises were
performed two to four times daily.
Patellar braces are non-adhesive devices that, like tap-
ing, apply an external, medially directed force that may
counteract lateral patellar maltracking. Draper et al. [13]
have demonstrated by real-time MRI that a knee brace
that applies a medially directed force on the patella can
reduce patellar lateralization and tilt in women with
PFPS significantly better than a bandage. Powers et al.
[25] analyzed an orthosis that applied a medially directed
force on the patella in PFPS patients and reported de-
creased pain and increased activation of the quadriceps.
Selfe et al. [26,27] investigated the effect of patellar bra-
cing and taping on the three-dimensional mechanics of
the knee during a controlled step-down task in healthy
and PFPS patients. These studies showed that bracing
and taping offered coronal-plane and torsional control
of the patella during eccentric contraction of the quadri-
ceps in both PFPS patients and healthy subjects [26-29].
In addition to these biomechanical effects, Thijs et al.
[30] showed that there was a significantly higher level of
neuromotor and proprioceptive function with the appli-
cation of the brace and sleeve, respectively, than without
a brace or sleeve. Callaghan et al. [31] have shown that
patellar taping modulates brain activity in several areas
of the brain during a proprioceptive knee movement task.
According to the meta-analysis published by D'hondt et al.
[32], the use of a patellar brace has positive effects on
pain, function (Kjuala score), and patellofemoral congru-
ence angle compared with an untreated control group.
However, because of the low quality of the studies, the au-
thors concluded that this evidence should be regarded as
limited. Warden et al. [33] also found disputable evidence
for the use of orthoses in PFPS patients. In this meta-
analysis, only one of three studies reported a significant ef-
fect with a medially directed patella brace, whereas in the
other two studies the effect was not significant. In these
studies no difference was found between medially directed
bracing and sham bracing.
Therefore, we conclude that there is a need for further
well-designed studies to evaluate the effect of patellar
bracing on pain in PFPS. The Patella Pro (Otto Bock,
Duderstadt, Germany) is a new knee brace designed to
apply a medially directed force on the patella to counteract
lateral maltracking. The main characteristic of this patella
brace is the dynamic tracking system. The risk of improper
tracking of the patella is particularly high for flexion angles
between 0 and 30 degrees, when the patella is not guided
by the patellofemoral groove. The tracking system of the
Patella Pro was designed with a sleeve that can apply a dy-
namic medially directed force on the patella and track the
patella within this range of motion. The pressure from the
tracking system decreases with increasing flexion angle
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not needed. The ability of this brace to counteract lateral
patellar maltracking, thus improving biomechanical func-
tion, was demonstrated in a biomechanical cadaver study
at the German Sports University in Cologne [28], which
showed that the Patella Pro has the potential to medialize
the patella during the entire range of motion.
The Patella Pro clinical trial will target patients 18–50
years of age presenting with symptoms of PFPS. The de-
tails of the study protocol are presented here. Our hy-
pothesis is that there is a synergistic effect between the
Patella Pro brace and exercise.Figure 1 Flow chart of the study design.Methods/Design
Study design
This study is a randomized clinical trial examining the
short-term effectiveness of a patellar brace (Patella Pro,
Otto Bock, Duderstadt, Germany) in combination with
exercise and information on the mechanism of PFPS,
compared with exercise and information on the mechan-
ism of PFPS only (Figure 1). The study design is based
on the protocol of an intervention study for the treat-
ment of PFPS with exercise [29].
This study design was approved by the medical eth-
ics committee of the medical faculty of the Charité—
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ten informed consent.
The study protocol is registered with the Deutsches
Register Klinischer Studien (“German Clinical Trials Regis-
ter”) as DRKS-ID number DRKS00003291.
Study centers
This study is a multicenter clinical trial. Patients were
recruited from the following hospitals and orthopedic
practices:
1. Klinik für Orthopädie und Unfallchirurgie, Martin
Luther Krankenhaus, Berlin Grunewald, Germany
2. Arcus Sportklinik, Pforzheim, Germany
3. Asklepios, Harzkliniken GmbH, Fritz-König-Stift,
Bad Harzburg, Germany
4. Orthopädische Gemeinschaftspraxis, Berlin,
Germany
5. Klinik für Unfall-, Hand-, und
Wiederherstellungschirurgie, Universitätsklinikum
Münster, Germany
6. Orthopädische Klinik, Rosenheim, Germany.
The clinical outcome parameters will be collected and
analyzed at the Klinik für Orthopädie und Unfallchirurgie,
Martin Luther Krankenhaus, Berlin Grunewald, Germany.
Patient selection
Adults aged 18–50 years with PFPS symptoms lasting
longer than 2 months but not longer than 2 years are
eligible to participate. The recruitment period took place
from April 2012 to October 2013. The first results of the
study will be available in 2014.
Inclusion and exclusion criteria
Inclusion criteria are age between 18 and 50 years and
the presence of three of the following symptoms lasting
longer than 2 months but not longer than 2 years: An-
terior knee pain when running, climbing stairs, cycling,
sitting with a bent knee, or performing squats. Pain level
is not an inclusion criterion.
Exclusion criteria include the following: Kellgren-
Lawrence grade 3 to grade 4 osteoarthritis [35]; local grade
3 to grade 4 cartilage damage on MRI, measured using the
Gluckert grading system [36]; subluxation of the patella;
previous knee injury (cruciate ligaments); tendinosis of the
patellar tendon; Osgood-Schlatter disease; osteochondritis
dissecans; valgus with more than 3 fingerbreadths of inter-
malleolar distance; and varus with more than 2 finger-
breadths of intercondylar distance.
Diagnoses are made on the basis of medical history, clin-
ical findings, and existing x-ray and magnetic resonance
imaging (MRI) scans. Patients without existing MRI and
x-ray were not recruited.Informed consent
Patients who qualify as study participants on the basis of
inclusion and exclusion criteria are informed about the
study. This information includes written general infor-
mation on patellofemoral pain syndrome and a written
description of the present study. These instructions in-
clude information about the purpose of the study and
potential risks. All participants must sign an informed-
consent form.
Sample size calculation
In an intervention study by Clark et al. [37], the difference
in recovery rates between the intervention and control
groups was 22%. This difference was statistically significant
(power 0.8, alpha 0.05). With a potential dropout rate of
about 5-10%, approximately 144 patients (135 patients +10
patients) must be enrolled in this study (power 0.80, alpha
0.05).
Intervention
The two treatment groups in this trial undergo the fol-
lowing interventions:
Group 1: Patients receive written information about
the program, including schematic drawings of the five
PFPS exercises, which they perform on their own (home
exercise) in a structured program (Patella Move). The
five exercises are as follows: Sitting and flexing the knee,
sitting and tensing the quadriceps, two-legged stance
and squat, one-legged stance and squat, and one-legged
stance and lateral pressure. Patients are instructed to
complete the three sets of six repetitions per leg over
the course of the day and to take a break the following
day. The duration of the Patella Move program is not
limited. The Patella Move program involves gradually
increasing intensity to a maximum that is determined
individually on the basis of actual symptoms [34]. The
instruction sheet tells patients: “Do not stress yourself”
and “If you feel insecure, leave out an exercise”.
Supervised exercises: Study participants receive a
Krankengymnastik am Gerät (“prescription for physical
therapy using the device”). In Germany, Krankengymnastik
am Gerät is regulated by law (§ 125 Abs. 1 SGB V vom1.
August 2001 in der Fassung vom 1. Juni 2006) [38]. The
diagnosis patellofemoral pain syndrome is noted on the
prescription. This prescription ensures a structured train-
ing program using the following exercises or devices:
Functional leg press, treadmill, ergometer, stepper, angle
table, and vertical pull apparatus. After a detailed analysis,
the physical therapist creates a customized training plan
for each patient [38]. The goal of Krankengymnastik am
Gerät is to improve strength, coordination, endurance,
and flexibility of the lower extremity, including the hip
muscles (38). The duration of one session is 60 minutes
(38). The prescription is accompanied by detailed
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physiotherapist. Although patients in group 1 will not be
wearing the Patella Pro device, this approach ensures that
the training program designed for this diagnosis at all
study centers in Germany is largely homogeneous. The
duration of the supervised exercise program is 6 weeks
(12 units). The costs of physiotherapy are covered by Otto
Bock.
Group 2: Patients receive detailed information about
PFPS; written information about the program and instruc-
tions on Patella Move exercises, which they perform as a
structured home-exercise program; and supervised physio-
therapy, all as described for group 1. However, in this
group, study participants also receive a patellar brace
(Patella Pro) (Figure 2, consent from the patient for this
image to be published was obtained). Medially directed
force is applied to the patella by a tracking system. The
brace is adapted to the patient by the study physician at
the study center, and its function is explained to the pa-
tient. Study participants also receive appropriate patient
information about the Patella pro brace provided by Otto
Bock. They are instructed to use the orthosis over a period
of 6 weeks for at least 6 hours a day.Co-interventions
During the 1-year course of the study, the following co-
interventions are allowed: Application of ice, ointment
dressings, and consumption of oral analgesics (nonsteroi-
dal anti-inflammatory drugs or paracetamol). Patients are
asked to report on co-interventions after 6 weeks and
3 months and during the 1-year follow-up.Figure 2 Patellar brace (Patella Pro, Otto Bock, Duderstadt, Germany)
patella. Consent from the patient for this image to be published was obtaiRandomization
After patients are recruited and informed consent has been
obtained, the patients are randomized to the two treatment
groups. All study centers receive the randomization docu-
ments in a sealed envelope. After opening the envelope,
the group to which each patient is assigned can be seen.
Patients are allocated to either group 1 or group 2.
Baseline examination
The following data are collected during the baseline exam-
ination: Date; patient age, sex, and contact information;
left or right knee, symptoms, and current treatment; med-
ical history; clinical examination findings, including range
of motion, stability tests (Lachman, pivot-shift, and poster-
ior drawer tests); meniscus signs; intra-articular effusion;
soft-tissue swelling; circumference measurements; and leg
axis, including intercondylar and intermalleolar distances.
Data processing
Patient name and contact information, along with the
results of the baseline examination, are transmitted to
the evaluation center (Martin Luther Hospital, Berlin).
After evaluation, the data are processed anonymously.
Any publication of the data is also done anonymously.
Outcome parameters
Primary outcome measures are subjective assessments of
recovery using a seven-point Likert scale [29,37] at
3 months and 1 year. This parameter was used for the
sample size calculation.
Secondary outcome measures are subjective assessment
of recovery using a seven-point Likert scale at 6 weeks;. The sleeve of the brace can apply a medially directed force on the
ned.
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ters muscular atrophy and flexion; the German version
of the Knee Injury and Osteoarthritis Outcome Score
(KOOS) [40,41]; pain at rest and with walking, stair climb-
ing, sitting and sports activity, reported on a numerical
scale (0 to 100); and review of compliance and additional
interventions. All these measurements are evaluated via
questionnaire at baseline, 6 weeks, 3 months and 1 year.
The seven-point (completely recovered, strongly recov-
ered, significant improvement, moderate improvement, lit-
tle improvement, slightly recovered, worse than ever) Likert
scale used in the present study was used previously by Van
Linschoten et al. [29] to study the effect of supervised
physiotherapy on PFPS patients (Table 1). Patients were
deemed to have recovered if they rated themselves fully re-
covered or strongly recovered, whereas those who rated
themselves slightly recovered to worse than ever were
deemed not to have recovered. This threshold was used to
dichotomize perceived recovery into two clear categories:
“recovered” and “not recovered”.
The Kujala score is a disease-specific, validated disabil-
ity scale for patellofemoral disorders that ranges from 0
(complete disability) to 100 (fully functional) [39].
The validated German version of the KOOS is self-
explanatory and consists of five subscales; pain, symptoms,
sports/recreational activities, activities of daily living, and
function [40]. Standardized answer options are given (five
Likert boxes), and each question is assigned a score from
0 to 4. A normalized score (100 indicating no symptoms
and 0 indicating extreme symptoms) is calculated for each
subscale [40,41]. A total score has not been validated and
is not recommended [40].
Pain at rest and with walking, stair climbing, sitting,
and sports activity is marked by the patient on a numer-
ical scale (0 to 100).
All patients are asked during telephone interviews at
6, 12, and 54 weeks if they have adhered to treatment. It
is noted if they have not continued using the brace, per-
formed the home-exercise program, or attended super-
vised physiotherapy sessions.
Expected results
In the study of Clark et al. [37], functional recovery was
significantly higher in a group of PFPS patients who per-














Patients were classified to have recovered if they rated themselves fully recovered o
than ever were classified as not recovered.the passive realignment provided by the Patella Pro brace
decreases pain during exercises. Therefore, we expect that
the exercises in group 2 are more effective than in group
1. This should result in a significantly higher rate of recov-
ery in group 2.
Van Linschoten et al. [29] observed a decrease in pain
at rest and with activity as well as an increase in func-
tion after 3 months in a group receiving supervised
physiotherapy. Therefore, decreased pain and increased
function are also expected in all patients in the present
study. The hypothesis of this study is that patients using
the brace will experience greater improvements (higher
scores) in the KOOS subscales and Kujala score and
greater reductions in pain than non-braced patients.
Statistical analyses
To evaluate additional effects of the patellar brace on su-
pervised exercise and home exercise in patients with
PFPS, between-group differences in clinical outcomes
will be analyzed on the basis of intention to treat. Logis-
tic regression techniques are used for dichotomous out-
come parameters. Continuous outcomes will be analyzed
with linear regression techniques. Recovery, as measured
by the seven-point Likert scale, will be dichotomized to
recovered (fully or strongly) or not recovered (slightly to
strongly worsened). Other outcome measures will be an-
alyzed as continuous variables.
Statistical analyses are performed at Medistat, Kiel,
Germany.
Discussion
The Patella Pro study was designed after reviewing the
literature on therapy for patients with PFPS [9,29]. The
PEX study protocol published by Van Linschoten et al.
[9] served as the model for this trial because it is a high-
quality protocol for a trial examining an intervention for
patients with a PFPS.
Treatment options for PFPS patients are patellar tap-
ing and bracing [7]. The exact mechanism of action of
both modalities is unknown. Some authors have been
able to demonstrate biomechanical effects of taping and
brace application; others have demonstrated improved
proprioception and effects on brain activity [30,31]. A
meta-analysis of studies limited in number and quality
















r strongly recovered. Those who rated themselves as slightly recovered to worse
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of patellar bracing [33] could also be the result of the
brace design. The present study will contribute to the
elucidation of this research question. We expect an an-
swer about the clinical effect of the Patellar pro brace
for the treatment of PFPS. Unfortunately we cannot an-
swer if the effect is due to the medially directed force or
a proprioceptive effect.
Based on the available literature regarding tape appli-
cation in PFPS patients [33,42,43], our research group
expects to discover benefits of brace treatment, includ-
ing perceived recovery and improvements in pain sever-
ity and functional disability, in the Patella Pro study.
A limitation of the present study design is that only pa-
tients with an existing MRI and x-ray are included. This
could be a selection bias, as only those patients with
greater attention to their pathological condition are se-
lected. Another limitation could be the age band going up
to 50 as this group may have other symptoms. However,
the exclusion criteria will mediate against some of these.
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